Management of Hepatocellular Carcinoma in Japan

Overview

Journal J Gastroenterol

Specialty Gastroenterology

Date 2006 Mar 29

PMID 16568368

Citations 14

Authors

Kiwamu Okita

Affiliations

Soon will be listed here.

Citing Articles

Clinical Outcomes of Switching from Zoledronic Acid to Denosumab for the Management of Severe Bone Metastasis from Hepatocellular Carcinoma: A Single-Center, Open-Label, Prospective Intervention Trial.

Naruto K, Kawaoka T, Yamasaki S, Kosaka M, Shirane Y, Johira Y Yonago Acta Med. 2023; 66(4):422-431.

PMID: 38028262 PMC: 10674054. DOI: 10.33160/yam.2023.11.007.

Efficacy and safety of chemoradiation therapy using one-shot cisplatin via hepatic arterial infusion for advanced hepatocellular carcinoma with major macrovascular invasion: a single-arm retrospective cohort study.

Naruto K, Kawaoka T, Kodama K, Ogawa Y, Amioka K, Yoshikawa Y BMC Gastroenterol. 2022; 22(1):275.

PMID: 35655156 PMC: 9161561. DOI: 10.1186/s12876-022-02359-x.

The importance of body composition assessment for patients with advanced hepatocellular carcinoma by bioelectrical impedance analysis in lenvatinib treatment.

Yamaoka K, Kodama K, Kawaoka T, Kosaka M, Johira Y, Shirane Y PLoS One. 2022; 17(1):e0262675.

PMID: 35041693 PMC: 8765661. DOI: 10.1371/journal.pone.0262675.

Consensus on the secondary prevention of primary liver cancer.

Nan Y, Xu X, Gao Y, Wang R, Li W, Yang M Hepatol Int. 2021; 15(6):1289-1300.

PMID: 34846705 PMC: 8712303. DOI: 10.1007/s12072-021-10259-7.

Complete Response for Advanced Hepatocellular Carcinoma by Conversion Surgery Therapy Following a Good Response of Regorafenib Despite Rapid Progressive Disease with Sorafenib.

Yamaoka K, Kawaoka T, Aikata H, Ando Y, Kosaka Y, Suehiro Y Intern Med. 2021; 60(13):2047-2053.

PMID: 34193774 PMC: 8313913. DOI: 10.2169/internalmedicine.5870-20.

References

Ikai I, Arii S, Ichida T, Okita K, Omata M, Kojiro M . Report of the 16th follow-up survey of primary liver cancer. Hepatol Res. 2005; 32(3):163-72. DOI: 10.1016/j.hepres.2005.04.005. View

Lin S, Lin C, Lin C, Hsu C, Chen Y . Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm. Gastroenterology. 2004; 127(6):1714-23. DOI: 10.1053/j.gastro.2004.09.003. View

Habu D, Shiomi S, Tamori A, Takeda T, Tanaka T, Kubo S . Role of vitamin K2 in the development of hepatocellular carcinoma in women with viral cirrhosis of the liver. JAMA. 2004; 292(3):358-61. DOI: 10.1001/jama.292.3.358. View

Toyoda H, Kumada T, Nakano S, Takeda I, Sugiyama K, Kiriyama S . Effect of the dose and duration of interferon-alpha therapy on the incidence of hepatocellular carcinoma in noncirrhotic patients with a nonsustained response to interferon for chronic hepatitis C. Oncology. 2001; 61(2):134-42. DOI: 10.1159/000055364. View

Seki T, Wakabayashi M, Nakagawa T, Itho T, SHIRO T, Kunieda K . Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma. Cancer. 1994; 74(3):817-25. DOI: 10.1002/1097-0142(19940801)74:3<817::aid-cncr2820740306>3.0.co;2-8. View

Kudo M, Chung H, Osaki Y . Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score). J Gastroenterol. 2003; 38(3):207-15. DOI: 10.1007/s005350300038. View

Iwatsuki S, Gordon R, Shaw Jr B, Starzl T . Role of liver transplantation in cancer therapy. Ann Surg. 1985; 202(4):401-7. PMC: 1250934. DOI: 10.1097/00000658-198510000-00001. View

Calvet X, Bruix J, Gines P, Bru C, Sole M, Vilana R . Prognostic factors of hepatocellular carcinoma in the west: a multivariate analysis in 206 patients. Hepatology. 1990; 12(4 Pt 1):753-60. DOI: 10.1002/hep.1840120422. View

Kasahara A, Hayashi N, Mochizuki K, Takayanagi M, Yoshioka K, Kakumu S . Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group. Hepatology. 1998; 27(5):1394-402. DOI: 10.1002/hep.510270529. View

10.

Taketa K, Endo Y, SEKIYA C, Tanikawa K, Koji T, Taga H . A collaborative study for the evaluation of lectin-reactive alpha-fetoproteins in early detection of hepatocellular carcinoma. Cancer Res. 1993; 53(22):5419-23. View

11.

Sanyal A . AGA technical review on nonalcoholic fatty liver disease. Gastroenterology. 2002; 123(5):1705-25. DOI: 10.1053/gast.2002.36572. View

12.

Makuuchi M, Hasegawa H, Yamazaki S . Ultrasonically guided subsegmentectomy. Surg Gynecol Obstet. 1985; 161(4):346-50. View

13.

Muto Y, Moriwaki H, Saito A . Prevention of second primary tumors by an acyclic retinoid in patients with hepatocellular carcinoma. N Engl J Med. 1999; 340(13):1046-7. DOI: 10.1056/NEJM199904013401315. View

14.

McCullough A . Update on nonalcoholic fatty liver disease. J Clin Gastroenterol. 2002; 34(3):255-62. DOI: 10.1097/00004836-200203000-00013. View

15.

Kasugai H, Kojima J, Tatsuta M, Okuda S, Sasaki Y, Imaoka S . Treatment of hepatocellular carcinoma by transcatheter arterial embolization combined with intraarterial infusion of a mixture of cisplatin and ethiodized oil. Gastroenterology. 1989; 97(4):965-71. DOI: 10.1016/0016-5085(89)91505-9. View

16.

Yamada R, Sato M, Kawabata M, Nakatsuka H, Nakamura K, Takashima S . Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology. 1983; 148(2):397-401. DOI: 10.1148/radiology.148.2.6306721. View

17.

Minagawa M, Makuuchi M, Takayama T, Kokudo N . Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma. Ann Surg. 2003; 238(5):703-10. PMC: 1356149. DOI: 10.1097/01.sla.0000094549.11754.e6. View

18.

Okanoue T, Itoh Y, Minami M, Sakamoto S, Yasui K, Sakamoto M . Interferon therapy lowers the rate of progression to hepatocellular carcinoma in chronic hepatitis C but not significantly in an advanced stage: a retrospective study in 1148 patients. Viral Hepatitis Therapy Study Group. J Hepatol. 1999; 30(4):653-9. DOI: 10.1016/s0168-8278(99)80196-2. View

19.

Takasaki K . [Hepatic resection using glissonean pedicle transection]. Nihon Geka Gakkai Zasshi. 1998; 99(4):245-50. View

20.

. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators. Hepatology. 1998; 28(3):751-5. DOI: 10.1002/hep.510280322. View